Phase II study of ganetespib, an hsp-90 inhibitor, in patients with refractory metastatic colorectal cancer Meeting Abstract


Authors: Cercek, A.; Shia, J. R.; Gollub, M.; Raasch, P. J.; Hollywood, E.; Reidy, D. L.; Janjigian, Y. Y.; Stadler, Z. K.; Segal, N. H.; O'Reilly, E. M.; Ilson, D.; Kemeny, N. E.; Saltz, L.
Abstract Title: Phase II study of ganetespib, an hsp-90 inhibitor, in patients with refractory metastatic colorectal cancer
Meeting Title: 2012 Gastrointestinal Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 30
Issue: 4 Suppl.
Meeting Dates: 2012 Jan 19-21
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2012-02-01
Language: English
ACCESSION: WOS:000209849300461
DOI: 10.1200/jco.2012.30.4_suppl.467
PROVIDER: wos
Notes: Meeting Abstract: 467 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Leonard B Saltz
    791 Saltz
  2. Marc J Gollub
    209 Gollub
  3. Neil Howard Segal
    210 Segal
  4. Zsofia Kinga Stadler
    391 Stadler
  5. Diane Lauren Reidy
    294 Reidy
  6. Yelena Yuriy Janjigian
    395 Janjigian
  7. Jinru Shia
    720 Shia
  8. David H Ilson
    433 Ilson
  9. Eileen O'Reilly
    780 O'Reilly
  10. Nancy Kemeny
    544 Kemeny